SEC Company Response from PAVmed Inc. (PAVM) (CIK 0001624326) (PAVM) — Apr 20, 2020
PAVmed Inc. (PAVM) (CIK 0001624326)
Date: April 20, 2020 · CIK: 0001624326 · Accession: 0001493152-20-006775
AI Filing Summary & Sentiment
File numbers found in text: 333-235335
Show Raw Text
CORRESP
1
filename1.htm
PAVMED
INC.
One
Grand Central Place, Suite 4600
New
York, New York 10165
April
20, 2020
Securities
and Exchange Commission
Division
of Corporation Finance
Washington,
District of Columbia 20549
Re:
PAVmed
Inc.
Registration
Statement on Form S-3
Originally
Filed December 3, 2019
File
No. 333-235335
Ladies
and Gentlemen:
Reference
is made to our letter filed as correspondence via EDGAR on April 15, 2020, in which we requested the acceleration of the effectiveness
of the above-referenced Registration Statement for April 17, 2020, at 4:30 p.m. Eastern Time, in accordance with Rule 461 of the
Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at such
time and we hereby formally withdraw our request for acceleration of the effective date. We will advise you as soon as possible
once we are ready to again request effectiveness of the Registration Statement.
Sincerely,
PAVMED
INC.
By:
/s/
Dennis M. McGrath
Name:
Dennis
M. McGrath
Title:
President
and Chief Financial Officer